FORTAMET Side Effects

7016163-8 | Lactic Acidosis, Myocardial Infarction, Po2 Abnormal, Renal Failure Acute
on Sep 14, 2010 Male patient from ITALY , 53 years of age, was diagnosed with diabetes mellitus and was treated with Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, myocardial infarction, po2 abnormal, renal failure acute. Fortamet dosage: 850 Mg, Tid. Patient was hospitalized.

7006339-8 | Blood Creatinine Increased, Metabolic Acidosis
Patient was taking Fortamet (View Usage). Patient had the following side effects: blood creatinine increased, metabolic acidosis on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 67 years of age, was diagnosed with type 2 diabetes mellitus and. Fortamet dosage: Unk. Patient was hospitalized.

6989330-7 | Hypophosphataemia, Infection, Overdose
Adverse event was reported on Sep 06, 2010 by a Female patient taking Fortamet (View Usage) (Dosage: 850 Mg, Tid) . Location: FRANCE , 67 years of age, After Fortamet was administered, patient had the following side effects: hypophosphataemia, infection (What is infection?), overdose.

6934508-1 | Blood Glucose Increased, Hyperkalaemia, Metabolic Acidosis, Renal Failure
on Aug 09, 2010 Female patient from UNITED KINGDOM , 82 years of age, was diagnosed with diabetes mellitus, back pain (What is back pain?), hypertension and was treated with Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, hyperkalaemia, metabolic acidosis, renal failure. Fortamet dosage: 850 Mg, Tid. During the same period patient was treated with DICLOFENAC (50 Mg, Unk) (View Diclofenac Review and Diclofenac Label ), ENALAPRIL (WATSON LABORATORIES) (20 Mg , Unk) (View Enalapril (watson Laboratories) Review and Enalapril (watson Laboratories) Label ). Patient was hospitalized.


6909525-8 | Hepatotoxicity
on Jul 26, 2010 Male patient from SENEGAL , 61 years of age, was treated with Fortamet (View Usage). Patient had the following side effects: hepatotoxicity. Fortamet dosage: 500 Mg, Bid. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NIASPAN (View Niaspan Review and Niaspan Label ).

6654310-8 |
Patient was taking Fortamet (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 26 years of age, . Fortamet dosage: Unk. During the same period patient was treated with OXYCODONE HCL (Unk) (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

6654306-6 |
Adverse event was reported on Mar 22, 2010 by a Male patient taking Fortamet (View Usage) (Dosage: Unk) . Location: UNITED STATES , 54 years of age, . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), INSULIN (View Insulin Review and Insulin Label ), ROSIGLITAZONE (View Rosiglitazone Review and Rosiglitazone Label ).

6654302-9 |
on Mar 22, 2010 Female patient from UNITED STATES , 41 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: Unk. During the same period patient was treated with LOTENSIN /00909102/ (View Lotensin /00909102/ Review and Lotensin /00909102/ Label ).

6654297-8 |
on Mar 22, 2010 Female patient from UNITED STATES , 33 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: Unk. During the same period patient was treated with DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), SITAGLIPTIN (View Sitagliptin Review and Sitagliptin Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6654292-9 |
Patient was taking Fortamet (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, . Fortamet dosage: Unk. During the same period patient was treated with ALLOPURINOL (WATSON LABORATORIES) (Unk) (View Allopurinol (watson Laboratories) Review and Allopurinol (watson Laboratories) Label ).

6654291-7 |
Adverse event was reported on Mar 22, 2010 by a Female patient taking Fortamet (View Usage) (Dosage: Unk) . Location: UNITED STATES , 46 years of age, . During the same period patient was treated with LOTENSIN /00909102/ (View Lotensin /00909102/ Review and Lotensin /00909102/ Label ).

6654267-X |
on Mar 22, 2010 Female patient from UNITED STATES , 66 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: Unk. During the same period patient was treated with CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (Unk) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ).

6654265-6 |
on Mar 22, 2010 Female patient from UNITED STATES , 50 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: Unk.

6654264-4 |
Patient was taking Fortamet (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 38 years of age, . Fortamet dosage: Unk.

6654263-2 |
Adverse event was reported on Mar 22, 2010 by a Male patient taking Fortamet (View Usage) (Dosage: Unk) . Location: UNITED STATES , 50 years of age, .

6654258-9 |
on Mar 22, 2010 Female patient from UNITED STATES , 56 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: Unk. During the same period patient was treated with FLUOXETINE (Unk) (View Fluoxetine Review and Fluoxetine Label ), OLMESARTAN (View Olmesartan Review and Olmesartan Label ), ATORVISTATIN/AMLODIPINE (View Atorvistatin/amlodipine Review and Atorvistatin/amlodipine Label ).

6654235-8 |
on Mar 22, 2010 Male patient from UNITED STATES , 56 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: Unk. During the same period patient was treated with METOCLOPRAMIDE HYDROCHLORIDE (Unk) (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), TRAZODONE HYDROCHLORIDE (Unk) (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), OXYCODONE HCL (Unk) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), METHYLPHENIDATE HYDROCHLORIDE (Unk) (View Methylphenidate Hydrochloride Review and Methylphenidate Hydrochloride Label ), ZOLPIDEM TARTRATE (Unk) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

6652370-1 |
Patient was taking Fortamet (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, . Fortamet dosage: .

6652361-0 |
Adverse event was reported on Mar 22, 2010 by a Male patient taking Fortamet (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), BETA BLOCKER (View Beta Blocker Review and Beta Blocker Label ).

6652069-1 |
on Mar 22, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ).

6643468-2 | Electromechanical Dissociation, Intentional Overdose, Lactic Acidosis, Renal Failure Acute
on Mar 08, 2010 Female patient from CANADA , 49 years of age, was diagnosed with diabetes mellitus, hypertension and was treated with Fortamet (View Usage). After Fortamet was administered, patient had the following side effects: electromechanical dissociation, intentional overdose, lactic acidosis, renal failure acute. Fortamet dosage: 500 Mg X 60 Tablets. During the same period patient was treated with LISINOPRIL/HYDROCHLOROTHIAZIDE 20/12.5 (WATSON LABORATORIES) (20/12.5 Mg X 20-25 Tablets) (View Lisinopril/hydrochlorothiazide 20/12.5 (watson Laboratories) Review and Lisinopril/hydrochlorothiazide 20/12.5 (watson Laboratories) Label ).

6547500-6 | Diabetes Insipidus, Overdose, Pancreatitis, Renal Failure, Vomiting
Patient was taking Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes insipidus (What is diabetes insipidus?), overdose, pancreatitis, renal failure, vomiting on Jan 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 16 years of age, was diagnosed with blood glucose increased and. Fortamet dosage: 22 G, Daily. During the same period patient was treated with SIMVASTATIN (200 Mg, Unk) (View Simvastatin Review and Simvastatin Label ).

6534766-1 | Rhabdomyolysis
Adverse event was reported on Dec 30, 2009 by a Female patient taking Fortamet (View Usage) (Dosage: 500 Mg, Tid) was diagnosed with hyperinsulinaemia, mental disorder and. Location: ITALY , 25 years of age, Patient had the following side effects: rhabdomyolysis. During the same period patient was treated with AMISULPRIDE (200 Mg, Daily) (View Amisulpride Review and Amisulpride Label ).

6509180-5 | Capillary Leak Syndrome, Hypoglycaemia, Intentional Overdose, Lactic Acidosis
on Dec 08, 2009 Female patient from UNITED KINGDOM , 50 years of age, weighting 143.3 lb, was treated with Fortamet (View Usage). After Fortamet was administered, patient had the following side effects: capillary leak syndrome, hypoglycaemia, intentional overdose, lactic acidosis. Fortamet dosage: 34 G, Single (40 Tablets Of 850 Mg). During the same period patient was treated with CARBIMAZOLE (5 Mg, Bid) (View Carbimazole Review and Carbimazole Label ), OLANZAPINE (20 Mg, Daily) (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6509175-1 | Abdominal Pain, Dehydration, Diarrhoea, Disturbance In Attention, Intentional Overdose, Lactic Acidosis, Renal Failure Acute, Sedation, Tachycardia
on Dec 08, 2009 Male patient from UNITED KINGDOM , 45 years of age, was treated with Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, disturbance in attention, intentional overdose, lactic acidosis, renal failure acute, sedation, tachycardia. Fortamet dosage: Unk. During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ). Patient was hospitalized.

6244811-9 | Encephalopathy
Patient was taking Fortamet (View Usage). Patient had the following side effects: encephalopathy on Jun 19, 2009 from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF Additional patient health information: Male patient , 51 years of age, was diagnosed with blood glucose increased and. Fortamet dosage: 850 Mg, Daily. Patient was hospitalized.

6238803-3 | Coma, Hepatic Failure, Lactic Acidosis, Renal Failure, Rhabdomyolysis, Shock
Adverse event was reported on Jun 16, 2009 by a Female patient taking Fortamet (View Usage) (Dosage: 1500 Mg, Daily) was diagnosed with type 2 diabetes mellitus, alcohol abuse and. Location: ITALY , 42 years of age, After Fortamet was administered, patient had the following side effects: coma, hepatic failure, lactic acidosis, renal failure, rhabdomyolysis, shock. During the same period patient was treated with ALCOHOL /00002101/ (Unk) (View Alcohol /00002101/ Review and Alcohol /00002101/ Label ). Patient was hospitalized.

6238797-0 | Lactic Acidosis, Renal Failure Acute
on Jun 15, 2009 Female patient from AUSTRALIA , 68 years of age, was treated with Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, renal failure acute. Fortamet dosage: Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE W/TELMISARTAN (Unk) (View Hydrochlorothiazide W/telmisartan Review and Hydrochlorothiazide W/telmisartan Label ).

6238786-6 | Lactic Acidosis, Renal Failure Acute, Shock
on Jun 15, 2009 Female patient from AUSTRALIA , 61 years of age, was treated with Fortamet (View Usage). Patient had the following side effects: lactic acidosis, renal failure acute, shock. Fortamet dosage: Unk. During the same period patient was treated with FUROSEMIDE (WATSON LABORATORIES) (Unk) (View Furosemide (watson Laboratories) Review and Furosemide (watson Laboratories) Label ), CANDESARTAN W/HYDROCHLOROTHIAZIDE (Unk) (View Candesartan W/hydrochlorothiazide Review and Candesartan W/hydrochlorothiazide Label ).

6213543-5 | Pancreatitis Acute
Patient was taking Fortamet (View Usage). After Fortamet was administered, patient had the following side effects: pancreatitis acute on May 26, 2009 from SPAIN Additional patient health information: Female patient , 22 years of age, was diagnosed with polycystic ovaries and. Fortamet dosage: 850 Mg, Q8h. Patient was hospitalized.

6188710-X | Coagulopathy, Factor Vii Deficiency, Poisoning, Protein S Decreased
Adverse event was reported on May 04, 2009 by a Female patient taking Fortamet (View Usage) (Dosage: 76.5 G, Single) was diagnosed with suicide attempt and. Location: TURKEY , 20 years of age, Patient experienced the following unwanted or unexpected effects: coagulopathy, factor vii deficiency, poisoning (What is poisoning?), protein s decreased. Patient was hospitalized.

6157593-6 | Bladder Disorder, Blood Glucose Increased, Intestinal Obstruction, Kidney Infection
on Apr 08, 2009 Female patient from UNITED STATES , 70 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Fortamet (View Usage). Patient had the following side effects: bladder disorder, blood glucose increased, intestinal obstruction, kidney infection. Fortamet dosage: 1000 Mg, Bid. During the same period patient was treated with AMARYL (1 Mg, Qam) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6107159-9 | Abdominal Pain, Alopecia, Diarrhoea, Hypoglycaemia, Palpitations
on Mar 05, 2009 Female patient from UNITED STATES , 53 years of age, weighting 198.0 lb, was diagnosed with diabetes mellitus inadequate control and was treated with Fortamet (View Usage). After Fortamet was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alopecia, diarrhoea, hypoglycaemia, palpitations. Fortamet dosage: 1000 Mg Twice Daily Po. During the same period patient was treated with ACTOS (30 Mg Q Day Po) (View Actos Review and Actos Label ), AVANDIA (View Avandia Review and Avandia Label ).

6072595-6 |
Patient was taking Fortamet (View Usage). on Jan 28, 2009 from UNITED STATES Additional patient health information: Male patient , 64 years of age, . Fortamet dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6072593-2 | Cardio-respiratory Arrest
Adverse event was reported on Jan 28, 2009 by a Male patient taking Fortamet (View Usage) (Dosage: ) . Location: UNITED STATES , 43 years of age, Patient had the following side effects: cardio-respiratory arrest. During the same period patient was treated with GLIPIZIDE (WATSON LABORATORIES) (View Glipizide (watson Laboratories) Review and Glipizide (watson Laboratories) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6072592-0 |
on Jan 28, 2009 Female patient from UNITED STATES , 51 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: . During the same period patient was treated with NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), DOXEPIN (WATSON LABORATORIES) (View Doxepin (watson Laboratories) Review and Doxepin (watson Laboratories) Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ).

6072591-9 |
on Jan 28, 2009 Male patient from UNITED STATES , 76 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: . During the same period patient was treated with SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), L DOPA (View L-dopa Review and L-dopa Label ).

6072590-7 |
Patient was taking Fortamet (View Usage). on Jan 28, 2009 from UNITED STATES Additional patient health information: Female patient , 49 years of age, . Fortamet dosage: .

6072589-0 |
Adverse event was reported on Jan 28, 2009 by a Male patient taking Fortamet (View Usage) (Dosage: ) . Location: UNITED STATES , 37 years of age, . During the same period patient was treated with GLIPIZIDE (WATSON LABORATORIES) (View Glipizide (watson Laboratories) Review and Glipizide (watson Laboratories) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), UNK SUBSTANCE (View Unk Substance Review and Unk Substance Label ).

6072586-5 | Acidosis, Electromechanical Dissociation, Hypoglycaemia, Hypotension, Unresponsive To Stimuli
on Jan 28, 2009 Male patient from UNITED STATES , 38 years of age, was treated with Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, electromechanical dissociation, hypoglycaemia, hypotension, unresponsive to stimuli. Fortamet dosage: Amounts Unkown. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ).

6072585-3 |
on Jan 28, 2009 Male patient from UNITED STATES , 52 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: .

6072584-1 |
Patient was taking Fortamet (View Usage). on Jan 28, 2009 from UNITED STATES Additional patient health information: Male patient , 43 years of age, . Fortamet dosage: . During the same period patient was treated with KETOROLAC (WATSON LABORATORIES) (View Ketorolac (watson Laboratories) Review and Ketorolac (watson Laboratories) Label ), CARVEDILOL (WATSON LABORATORIES) (View Carvedilol (watson Laboratories) Review and Carvedilol (watson Laboratories) Label ), THIAZOLIDINEDIONE (View Thiazolidinedione Review and Thiazolidinedione Label ).

6072582-8 |
Adverse event was reported on Jan 28, 2009 by a Male patient taking Fortamet (View Usage) (Dosage: ) . Location: UNITED STATES , 55 years of age, .

6072580-4 |
on Jan 28, 2009 Male patient from UNITED STATES , 77 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: .

6072579-8 |
on Jan 28, 2009 Male patient from UNITED STATES , 29 years of age, was treated with Fortamet (View Usage). . Fortamet dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ).

6065482-0 |
Patient was taking Fortamet (View Usage). on Jan 28, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, . Fortamet dosage: . During the same period patient was treated with LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), ALLOPURINOL (WATSON LABORATORIES) (Unk) (View Allopurinol (watson Laboratories) Review and Allopurinol (watson Laboratories) Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ).

6055934-1 | Coma, Convulsion, Hypoglycaemia, Hypotension, Intentional Overdose, Lactic Acidosis
Adverse event was reported on Jan 16, 2009 by a Female patient taking Fortamet (View Usage) (Dosage: Maximal Possible Ingested Dose 126 X 500 Mg (63 G)) . Location: UNITED KINGDOM , 14 years of age, weighting 88.18 lb, Patient had the following side effects: coma, convulsion, hypoglycaemia, hypotension, intentional overdose, lactic acidosis. During the same period patient was treated with ATENOLOL (Maximal Possible Ingested Dose 28 X 50 Mg (1400 Mg)) (View Atenolol Review and Atenolol Label ), DICLOFENAC (WATSON LABORATORIES) (Maximal Possible Ingested Dose 14 X 75 Mg (1050 Mg)) (View Diclofenac (watson Laboratories) Review and Diclofenac (watson Laboratories) Label ). Patient was hospitalized.

5961516-X | Lactic Acidosis
on Nov 10, 2008 Female patient from UNITED KINGDOM , 33 years of age, was diagnosed with gestational diabetes and was treated with Fortamet (View Usage). After Fortamet was administered, patient had the following side effects: lactic acidosis. Fortamet dosage: 500 Mg, Bid. During the same period patient was treated with ETHANOL (Unk) (View Ethanol Review and Ethanol Label ), COCAINE (Unk) (View Cocaine Review and Cocaine Label ). Patient was hospitalized.

5926050-1 | Haemolytic Anaemia, Jaundice
on Oct 08, 2008 Female patient from ISRAEL , 68 years of age, was diagnosed with diabetes mellitus and was treated with Fortamet (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, jaundice (What is jaundice?). Fortamet dosage: 850 Mg, Tid.

5926049-5 | Haemolytic Anaemia, Hyperbilirubinaemia, Jaundice
Patient was taking Fortamet (View Usage). Patient had the following side effects: haemolytic anaemia, hyperbilirubinaemia, jaundice (What is jaundice?) on Oct 08, 2008 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 46 years of age, was diagnosed with hyperglycaemia and. Fortamet dosage: 500 Mg, Tid.